Unique features of human cathelicidin LL-37

BioFactors

Volumn 41, Issue 5, 2015, Pages 289-300

  Bandurska, Katarzyna ^a   Berdowska, Agnieszka ^a   Barczyńska Felusiak, Renata ^a   Krupa, Piotr ^a  

^a JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

Anti microbial properties; Cathelicidin; Immune system; Inflammation; LL 37

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; VITAMIN D; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; BIOFILM; CANCER CELL; CARCINOGENESIS; CELLS; CLINICAL FEATURE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; TUMOR GROWTH; VIRUS INFECTION; WOUND HEALING; CHEMISTRY; METABOLISM; PHYSIOLOGY;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; NEOPLASMS;

EID: 84944738598     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1225     Document Type: Review

References (207)

1. Chow, J. Y. C. H., Li, Z. J., Wu, W. K. K., and Cho, C. H. H. (2013) Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer. World J. Gastroentrol. 19, 2731-2735.
2. Andrault, P. M., Samsonov, S. A., Weber, G., Coquet, L., Nazmi, K., et al. (2015) Antimicrobial peptide LL-37 is both a substrate of cathepsins S and K and a selective inhibitor of cathepsin L. Biochemistry 54, 2785-2798.
3. Larrick, J. W., Morgan, J. G., Palings, I., Hirata, M., and Yen, M. H. (1991) Complementary DNA sequence of rabbit CAP18-a unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 179, 170-175.
4. Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., et al. (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63, 1291-1297.
5. Burton, M. F., and Steel, P. G. (2009) The chemistry and biology of LL-37. Nat. Prod. Rep. 26, 1572-1584.
6. Li, X., Li, Y., Han, H., Miller, D. W., and Wang, G. (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 128, 5776-5785.
7. Wang, G. (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 283, 32637-32643.
8. Dannehl, C., Gutsmann, T., and Brezesinski, G. (2013) Surface activity and structures of two fragments of the human antimicrobial LL-37. Colloids. Surf. B 109, 129-135.
9. Wang, G., Mishra, B., Epand, R. F., and Epand, R. M. (2014) High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochi. Biophys. Acta 1838, 2160-2172.
10. Kanthawong, S., Bolscher, J. G., Veerman, E. C., van Marle, J., Nazmi, K., et al. (2010) Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int. J. Antimicrob. Agents 36, 447-452.
11. Sørensen, O. E., Gram, L., Johnsen, A. H., Andersson, E., Bangsbøll, S., et al. (2003) Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J. Biol. Chem. 278, 28540-28546.
12. Yang, Y. X., Feng, Y., Wang, B. Y., and Wu, Q. (2004) PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities. Acta Pharmacol. Sin. 25, 239-245.
13. Li, Y., and Ye, D. (2013) Molecular biology for formyl peptide receptors in human diseases. J. Mol. Med. (Berl.) 91, 781-789.
14. Bergman, P., Johansson, L., Asp, V., Plant, L., Gudmundsson, G. H., et al. (2005) Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol. 7, 1009-1017.
15. Smeianov, V., Scott, K., and Reid, G. (2000) Activity of cecropin P1 and FALL-37 against urogenital microflora. Microbes Infect. 2, 773-777.
16. Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., et al. (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 68, 2748-2755.
17. Tanaka, D., Miyasaki, K. T., and Lehrer, R. I. (2000) Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human and epithelium. Oral Microbiol. Immunol. 15, 226-231.
18. Lee, S. H., Jun, H. K., Lee, H. R., Chung, P., and Choi, B. K. (2010) Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int. J. Antimicrob. Agents. 35, 138-145.
19. Hase, K., Murakami, M., Iimura, M., Cole, S. P., Horibe, Y., et al. (2003) Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125, 1613-1625.
20. Chromek, M., Arvidsson, I., and Karpman, D. (2012) The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease. PLoS One 7, e46476.
21. Vandamme, D., Landuyt, B., Luyten, W., and Schoofs, L. (2012) A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell. Immunol. 280, 22-35.
22. Feng, Y., Yang, Y., Huang, N., Wu, Q., and Wang, B. (2013) E. coli-based production of recombinant FALL-39. Sheng. Wu. Yi. Xue. Gong. Cheng. Xue. Za. Zhi. 20, 634-637.
23. Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R. A., and Gallo, R. L. (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172, 3070-3077.
24. Wong, J. H., Ng, T. B., Legowska, A., Rolka, K., Hui, M., et al. (2011) Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans. Peptides 32, 1996-2002.
25. Overhage, J., Campisano, A., Bains, M., Torfs, E. C., Rehm, B. H., et al. (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 76, 4176-4182.
26. Dean, S. N., Bishop, B. M., and van Hoek, M. L. (2011) Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37. Front. Microbiol. 2, 128.
27. Amer, L. S., Bishop, B. M., and van Hoek, M. L. (2010) Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem. Biophys. Res. Commun. 396, 246-251.
28. Barlow, P. G., Svoboda, P., Mackellar, A., Nash, A. A., York, I. A., et al. (2011) Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 6, e25333.
29. Howell, M. D., Jones, J. F., Kisich, K. O., Streib, J. E., Gallo, R. L., et al. (2004) Selective killing of vaccinia virus by LL-37 implications for eczema vaccinatum. J. Immunol. 172, 1763-1767.
30. Wong, J. H., Legowska, A., Rolka, K., Ng, T. B., Hui, M., et al. (2011) Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides 32, 1117-1122.
31. Gordon, Y. J., Huang, L. C., Romanowski, E. G., Yates, K. A., Proske, R. J., et al. (2005) Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye. Res. 30, 385-394.
32. Rico-Mata, R., De Leon-Rodriguez, L. M., and Avila, E. E. (2013) Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites. Exp. Parasitol. 133, 300-306.
33. Davidson, D. J., Currie, A. J., Reid, G. S., Bowdish, D. M., MacDonald, K. L., et al. (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172, 1146-1156.
34. Salvado, M. D., Di Gennaro, A., Lindbom, L., Agerberth, B., and Haeggström, J. Z. (2013) Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin. Arterioscler. Thromb. Vasc. Biol. 33, 1965-1972.
35. Li, J., Post, M., Volk, R., Gao, Y., Li, M., et al. (2000) PR39, a peptide regulator of angiogenesis. Nat. Med. 6, 49-55.
36. Pfosser, A., El-Aouni, C., Pfisterer, I., Dietz, M., Globisch, F., et al. (2010) NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37. Stem. Cells. 28, 376-385.
37. Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111, 1665-1672.
38. Ramos, R., Silvaa, J. P., Rodrigues, A. C., Costa, R., Guardão, L., et al. (2011) Wound healing activity of the human antimicrobial peptide LL37. Peptides. 32, 1469-1476.
39. Coffelt, S. B., Marini, F. C., Watson, K., Zwezdaryk, K. J., Dembinski, J. L., et al. (2009) The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc. Natl. Acad. Sci. USA 106, 3806-3811.
40. Wu, W. K. K., Wang, G., Coffelt, S. B., Betancourt, A. M., Lee, Ch, et al. (2010) Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int. J. Cancer. 127, 1741-1747.
41. von Haussen, J., Koczulla, R., Shaykhiev, R., Herr, C., Pinkenburg, O., et al. (2008) The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung. Cancer. 59, 12-23.
42. Heilborn, J. D., Nilsson, M. F., Jimenez, C. I., Sandstedt, B., Borregaard, N., et al. (2005) Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int. J. Cancer. 114, 713-719.
43. Zwezdaryk, K. J., Tomchuck, S. L., LaMarca, H. L., Danka, E. S., Morris, C. A., et al. (2008) Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int. J. Cancer. 122, 1030-1039.
44. Wang, G. (2014) Human antimicrobial peptides and proteins. Pharmaceuticals 7, 545-594.
45. Valore, E. V., Park, C. H., Quayle, A. J., Wiles, K. R., McCray, P. B., et al. Human beta-defensin-1: An antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633-1642.
46. Sorensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951-3959.
47. Anderson, R. C., Rehders, M., and Yu, P. L. (2008) Antimicrobial fragments of the pro-region of cathelicidins and other immune peptides. Biotechnol. Lett. 30, 813-818.
48. Morizane, S., Yamasaki, K., Kabigting, F. D., and Gallo, R. L. (2010) Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J. Invest. Dermatol. 130, 1297-1306.
49. Hieshima, K., Ohtani, H., Shibano, M., Izawa, D., Nakayama, T., et al. (2003) CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170, 1452-1461.
50. Pazgier, M., Ericksen, B., Ling, M., Toth, E., Shi, J., et al. (2013) Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Biochemistry 52, 1547-1558.
51. Reinholz, M., Ruzicka, T., and Schauber, J. (2012) Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann. Dermatol. 24, 126-135.
52. Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wojcik, K., Puklo, M., et al. (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents. Chemother. 48, 4673-4679.
53. Krijgsveld, J., Zaat, S. A., Meeldijk, J., van Veelen, P. A., Fang, G., et al. (2000) Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J. Biol. Chem. 275, 20374-20381.
54. Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R. A., et al. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068-2080.
55. Eissa, A., Amodeo, V., Smith, C. R., and Diamandis, E. P. (2011) Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J. Biol. Chem. 286, 687-706.
56. Kanada, K. N., Nakatsuji, T., and Gallo, R. L. (2012) Doxycycline indirectly inhibits proteolytic activation of tryptickallikrein-related peptidases and activation of cathelicidin. J. Invest. Dermatol. 132, 1435-1442.
57. Frohm, M., Agerberth, B., Ahangari, G., Stahle-Backdahl, M., Liden, S., et al. (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272, 15258-15263.
58. Kim, B. J., Rho, Y. K., Lee, H. I., Jeong, M. S., Li, K., et al. (2009) The effect of calcipotriol on the expression of human beta defensin-2 and LL-37 in cultured human keratinocytes. Clin. Dev. Immunol. 2009, 645898.
59. Hase, K., Eckmann, L., Leopard, J. D., Varki, N., and Kagnoff, M. F. (2002) Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70, 953-963.
60. Bals, R., Wang, X., Zasloff, M., and Wilson, J. M. (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95, 9541-9546.
61. Frohm, N. M., Sandstedt, B., Sorensen, O., Weber, G., Borregaard, N., et al. (1999) The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67, 2561-2566.
62. Lee, Ch-, J., Buznyk, O., Kuffova, L., Rajendran, V., Forrester, J. V., et al. (2014) Cathelicidin LL-37 and HSV-1 corneal infection: peptide versus gene therapy. Transl. Vis. Sci. Technol. 3, 1-14.
63. Braff, M. H., Di, N. A., and Gallo, R. L. (2005) Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J. Invest. Dermatol. 124, 394-400.
64. Chakraborty, K., Maity, P. C., Sil, A. K., Takeda, Y., and Das, S. (2009) CAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor. J. Biol. Chem. 284, 21810-21827.
65. Sorensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F., and Borregaard, N. (1997) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796-2803.
66. Koon, H. W., Shih, D. Q., Chen, J., Bakirtzi, K., Hing, T. C., et al. (2011) Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Gastroenterology 141, 1852-1863.
67. Yang, D., de la Rosa, G., Tewary, P., and Oppenheim, J. J. (2009) Alarmins link neutrophils and dendritic cells. Trends. Immunol. 30, 531-537.
68. Büchau, A. S., Morizane, S., Trowbridge, J., Schauber, J., Kotol, P., et al. (2010) The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J. Immunol. 184, 369-378.
69. Sigurdardottir, S. L., Thorleifsdottir, R. H., Guzman, A. M., Gudmundsson, G. H., Valdimarsson, H., et al. (2012) The anti-microbial peptide LL-37 modulates immune responses in the palatine tonsils where it is exclusively expressed by neutrophils and a subset of dendritic cells. Clin. Immunol. 142, 139-149.
70. Sonawane, A., Santos, J. C., Mishra, B. B., Jena, P., Progida, C., et al. (2011) Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell. Microbiol. 13, 1601-1617.
71. Rivas-Santiago, B., Hernandez-Pando, R., Carranza, C., Juarez, E., Contreras, J. L., et al. (2008) Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immunol. 76, 935-941.
72. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., et al. (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
73. Di, N. A., Vitiello, A., and Gallo, R. L. (2003) Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274-2278.
74. Wu, W., Kim, C. H., Liu, R., Kucia, M., Marlicz, W., et al. (2012) The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia 26, 736-745.
75. Lowry, M. B., Guo., Ch., Borregaard, N., Gombart, A. F. (2014) Regulation of the human cathelicidin antimicrobial peptide gene by1α, 25-dihydroxyvitamin D3 in primary immune cells. J. Steroid. Biochem. Mol. Biol. 143, 183-191.
76. Aberg, K. M., Radek, K. A., Choi, E. H., Kim, D. K., Demerjian, M., et al. (2007) Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J. Clin. Invest. 117, 3339-3349.
77. Chakraborty, K., Ghosh, S., Koley, H., Mukhopadhyay, A. K., Ramamurthy, T., et al. (2008) Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell. Microbiol. 10, 2520-2537.
78. Williams, M. R., Sakurai, Y., Zughaier, S. M., Eskin, S. G., and McIntire, L. V. (2009) Transmigration across activated endothelium induces transcriptional changes, inhibits apoptosis, and decreases antimicrobial protein expression in human monocytes. J. Leukoc. Biol. 86, 1331-1343.
79. Sarker, P., Ahmed, S., Tiash, S., Rekha, R. S., Stromberg, R., et al. (2011) Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia a potential therapeutic strategy. PLoS One 6, e20637.
80. Peric, M., Koglin, S., Kim, S. M., Morizane, S., Besch, R., et al. (2008) IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol. 181, 8504-8512.
81. Duplantier, A. J., and van Hoek, M. L. (2013) The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds. Front. Immunol. 4, 1-14.
82. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773.
83. Gombart, A. F. (2009) The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future. Microbiol. 4, 1151-1165.
84. Park, K., Elias, P. M., Oda, Y., Mackenzie, D., Mauro, T., et al. (2011) Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor independent pathway. J. Biol. Chem. 286, 34121-34130.
85. Kida, Y., Shimizu, T., and Kuwano, K. (2006) Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1. Mol. Immunol. 43, 1972-1981.
86. Steinmann, J., Halldorsson, S., Agerberth, B., and Gudmundsson, G. H. (2009) Phenylbutyrate induces antimicrobial peptide expression. Antimicrob. Agents. Chemother. 53, 5127-5133.
87. Misawa, Y., Baba, A., Ito, S., Tanaka, M., and Shiohara, M. (2009) Vitamin D(3) induces expression of human cathelicidin antimicrobial peptide 18 in newborns. Int. J. Hematol. 90, 561-570.
88. Tangpricha, V., Judd, S. E., Ziegler, T. R., Hao, L., Alvarez, J. A., et al. (2014) LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adults. AIDS Res. Hum. Retroviruses 30, 670-676.
89. Agerberth, B., Grunewald, J., Castaños-Velez, E., Olsson, B., Jörnvall, H., et al. (1999) Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care. Med. 160, 283-290.
90. Murakami, M., Ohtake, T., Dorschner, R. A., Schittek, B., Garbe, C., et al. (2002) Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119, 1090-1095.
91. Andersson, E., Sørensen, O. E., Frohm, B., Borregaard, N., Egesten, A., et al. (2002) Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum. Reprod. 17, 2529-2534.
92. Nielsen, K. L., Dynesen, P., Larsen, P., Jakobsen, L., Andersen, P. S., et al. (2014) Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect. Immun. 82, 1572-1578.
93. Trend, S., Strunk, T., Hibbert, J., Kok, C. H., Zhang, G., et al. (2015) Antimicrobial protein and peptide concentrations and activity in human breast milk consumed by preterm infants at risk of late-onset neonatal sepsis. PLoS One 10, e0117038.
94. Tollin, M., Bergsson, G., Kai-Larsen, Y., Lengqvist, J., Sjövall, J., et al. (2005) Vernix caseosa as a multi-component defence system based on polypeptides, lipids, and their interactions. Cell Mol. Life Sci. 62, 2390-2399.
95. Murakami, M., Dorschner, R. A., Stern, L. J., Lin, K. H., and Gallo, R. L. (2005) Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr. Res. 57, 10-15.
96. Krahulec, J., Hyršová, M., Pepeliaev, S., Jílková, J., Cerny, Z., et al. (2010) High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli. Appl. Microbiol. Biotechnol. 88, 167-175.
97. Ramos, R., Domingues, L., and Gama, M. (2010) Escherichia coli expression and purification of LL37 fused to a family III carbohydrate-binding module from Clostridium thermocellum. Protein Expr. Purif. 71, 1-7.
98. Li, Y., Li, X., Li, H., Lockridge, O., and Wang, G. (2007) A novel method for purifying recombinant human host defense cathelicidin LL-37 by utilizing its inherent property of aggregation. Protein Expr. Purif. 54, 157-165.
99. Yang, Y. H., Zheng, G. G., Li, G., Zhang, X. J., Cao, Z. Y., et al. (2004) Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. Protein Expr. Purif. 37, 229-235.
100. Moon, J. Y., Henzler-Wildman, K. A., and Ramamoorthy, A. (2006) Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim. Biophys. Acta. 1758, 1351-1358.
101. Li, Y., Li, X., and Wang, G. (2006) Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr. Purif. 47, 498-505.
102. Bommarius, B., Jenssen, H., Elliott, M., Kindrachuk, J., Pasupuleti, M., et al. (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31, 1957-1965.
103. Gombart, A. F., Borregaard, N., and Koeffler, H. P. (2005) Human cathelicidin antimicrobial gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J. 19, 1067-1077.
104. Alvarez-Rodriguez, L., Lopez-Hoyos, M., Garcia-Unzueta, M., Amado, J. A., Cacho, P. M., et al. (2012) Age and low levels of circulating vitamin D are associated with impaired innate immune function. J. Leukoc. Biol. 91, 829-838.
105. White, J. H. (2010) Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J. Steroid. Biochem. Mol. Biol. 121, 234-238.
106. Khemtémourian, L., Killian, J. A., Höppener, J. W., and Engel, M. F. (2008) Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus. Exp. Diabetes. Res. 2008, 421287.
107. Scheetz, T., Bartlett, J. A., Walters, J. D., Schutte, B. C., Casavant, T. L., et al. (2002) Genomics-based approaches to gene discovery in innate immunity. Immunol. Rev. 190, 137-145.
108. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
109. Shahnawaz, M., and Soto, C. (2012) Microcin amyloid fibrils A are reservoir of toxic oligomeric species. J. Biol. Chem. 287, 11665-11676.
110. Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48.
111. Porre, S., Heinonen, S., Mäntyjärvi, R., Rytkönen-Nissinen, M., Perola, O, et al. (2005) Psoriasin, a calcium-binding protein with chemotactic properties is present in the third trimester amniotic fluid. Mol. Hum. Reprod. 11, 87-92.
112. Ostergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Orntoft, T. F., et al. (1997) Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer. Res. 57, 4111-4117.
113. Calderon Toledo, C., Rogers, T. J., Svensson, M., Tati, R., Fischer, H., et al. (2008) Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am. J. Pathol. 173, 1428-1439.
114. Heilborn, J. D., Nilsson, M. F., Kratz, G., Weber, G., Sørensen, O., et al. (2003) The cathelicidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389.
115. Niyonsaba, F., Iwabuchi, K., Someya, A., Hirata, M., Matsuda, H., et al. (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106, 20-26.
116. Dhall, S., Do, D., Garcia, M., Wijesinghe, D. S., Brandon, A., et al. (2014) A novel model of chronic wounds: importance of redox imbalance and biofilm-forming bacteria for establishment of chronicity. PLoS One 9, e109848.
117. Dean, S. N., Bishop, B. M., and van Hoek, M. L. (2011) Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol. 11, 114.
118. Schmidtchen, A., Frick, I. M., Andersson, E., Tapper, H., and Björck, L. (2001) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46, 157-168.
119. Coenye, T. (2010) Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation. FEMS Immunol. Med. Microbiol. 59, 239-252.
120. Cobo, E. R., He, C., Hirata, K., Hwang, G., Tran, U., et al. (2012) Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing. Infect. Immun. 80, 143-149.
121. Majchrzykiewicz, J. A., Kuipers, O. P., and Bijlsma, J. J. (2010) Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin. Antimicrob. Agents. Chemother. 54, 440-451.
122. Méndez-Samperio, P. (2010) The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 31, 1791-1798.
123. Lee, J. S., Yang, C. S., Shin, D. M., Yuk, J. M., Son, J. W., et al. (2009) Nitric oxide synthesis is modulated by 1, 25-dihydroxyvitamin D3 and interferon-gamma in human macrophages after mycobacterial infection. Immune. Network 9, 192-202.
124. Tsai, P. W., Cheng, Y. L., Hsieh, W. P., and Lan, C. Y. (2014) Responses of Candida albicans to the human antimicrobial peptide LL-37. J. Microbiol. 52, 581-589.
125. den Hertog, A. L., van Marle, J., van Veen, H. A., Van't Hof, W., Bolscher, J. G., et al. (2005) Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388, 689-695.
126. Wang, G., Watson, K. M., and Buckheit, R. W. (2008) Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob. Agents. Chemother. 52, 3438-3440.
127. Bergman, P., Walter-Jallow, L., Broliden, K., Agerberth, B., and Soderlund, J. (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr. HIV Res. 5, 410-415.
128. Tripathi, S., Tecle, T., Verma, A., Crouch, E., White, M., et al. (2013) The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J. Gen. Virol. 94, 40-49.
129. Crack, L. R., Jones, L., Malavige, G. N., Patel, V., and Ogg, G. S. (2012) Human antimicrobial peptides LL-37 and human beta-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. Clin. Exp. Dermatol. 37, 534-543.
130. Currie, S. M., Findlay, E. G., McHugh, B. J., Mackellar, A., Man, T., et al. (2013) The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One 8, e73659.
131. Jenssen, H., Hamill, P., and Hancock, R. E. (2006) Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491-511.
132. Steinstraesser, L., Tippler, B., Mertens, J., Lamme, E., Homann, H. H., et al. (2005) Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2, 2.
133. Lai, Y., Adhikarakunnathu, S., Bhardwaj, K., Ranjith-Kumar, C. T., Wen, Y, et al. (2011) LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One 6, e26632.
134. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y. H., et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569.
135. Takiguchi, T., Morizane, S., Yamamoto, T., Kajita, A., Ikeda, K., et al. (2014) Cathelicidin antimicrobial peptide LL-37 augments IFN-β expression and antiviral activity induced by double-stranded RNA in keratinocytes. Br. J. Dermatol. 171, 492-498.
136. 3. J. Cyst. Fibros. 6, 403-410.
137. Belderbos, M. E., Houben, M. L., Wilbrink, B., Lentjes, E., Bloemen, E. M., et al. (2011) Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 127, e1513-e1520.
138. Wu, W. K., Wong, C. C., Li, Z. J., Zhang, L., Ren, S. X., et al. (2010) Cathelicidins in inflammation and tissue repair: potential therapeutic applications for gastrointestinal disorders. Acta Pharmacol. Sin. 31, 1118-1122.
139. Metz-Boutigue, M. H., Shooshtarizadeh, P., Prevost, G., Haikel, Y., and Chich, J. F. (2010) Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules. Curr. Pharm. Des. 16, 1024-1039.
140. De, Y., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., et al. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptidereceptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral bloodneutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074.
141. Chertov, O., Michiel, D. F., Xu, L., Wang, J. M., Tani, K., et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271, 2935-2940.
142. Agerberth, B., and Gudmundsson, G. H. (2006) Host antimicrobial defence peptides in human disease. Curr. Top. Microbiol. Immunol. 306, 67-90.
143. Wuerth, K., and Hancock, R. E. (2011) New insights into cathelicidin modulation of adaptive immunity. Eur. J. Immunol. 41, 2817-2819.
144. Montreekachon, P., Chotjumlong, P., Bolscher, J. G., Nazmi, K., Reutrakul, V., et al. (2011) Involvement of P2X(7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts. J. Periodontal. Res. 46, 327-337.
145. Bowdish, D. M., Davidson, D. J., Speert, D. P., and Hancock, R. E. (2004) The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172, 3758-3765.
146. Tjabringa, G. S., Aarbiou, J., Ninaber, D. K., Drijfhout, J. W., Sorensen, O. E., et al. (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171, 6690-6696.
147. Tjabringa, G. S., Rabe, K. F., and Hiemstra, P. S. (2005) The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Pulm. Pharmacol. Ther. 18, 321-327.
148. Yu, J., Mookherjee, N., Wee, K., Bowdish, D. M., Pistolic, J., et al. (2007) Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J. Immunol. 179, 7684-7691.
149. Di Nardo, A., Braff, M. H., Taylor, K. R., Na, C., Granstein, R. D., et al. (2007) Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J. Immunol. 178, 1829-1834.
150. Choi, K. Y., Napper, S., and Mookherjee, N. (2014) Human cathelicidin LL-37 and its derivative IG-19 regulate IL-32-induced inflammation. Immunology 143, 68-80.
151. Mookherjee, N., Lippert, D. N., Hamill, P., Falsafi, R., Nijnik, A., et al. (2009) Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 183, 2688-2696.
152. Liu, P. T., Stenger, S., Tang, D. H., and Modlin, R. L. (2007) Cutting edge: vitamin D-mediated human antimicrobial activity against mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179, 2060-2063.
153. Pistolic, J., Cosseau, C., Li, Y., Yu, J. J., Filewod, N. C., et al. (2009) Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. J. Innate. Immunol. 1, 254-267.
154. Into, T., Inomata, M., Shibata, K., and Murakami, Y. (2010) Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts. Cell. Immunol. 264, 104-109.
155. Braff, M. H., Hawkins, M. A., Di, N. A., Lopez-Garcia, B., Howell, M. D., et al. (2005) Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174, 4271-4278.
156. Zughaier, S. M., Shafer, W. M., and Stephens, D. S. (2005) Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell. Microbiol. 7, 1251-1262.
157. Niyonsaba, F., Ushio, H., Hara, M., Yokoi, H., Tominaga, M., et al. (2010) Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J. Immunol. 184, 3526-3534.
158. Kahlenberg, J. M., Carmona-Rivera, C., Smith, C. K., and Kaplan, M. J. (2013) Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J. Immunol. 190, 1217-1226.
159. Tomasinsig, L., Pizzirani, C., Skerlavaj, B., Pellegatti, P., Gulinelli, S., et al. (2008) The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J. Biol. Chem. 283, 30471-30481.
160. Lee, M., Shi, X., Barron, A. E., McGeer, E., and McGeer, P. L. (2015) Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation. Biochem. Pharmacol. 94, 130-141.
161. Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., and Hancock, R. E. (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891.
162. Alalwani, S. M., Sierigk, J., Herr, C., Pinkenburg, O., Gallo, R., et al. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur. J. Immunol. 40, 1118-1126.
163. da Pinheiro, S. F., Gallo, R. L., and Nizet, V. (2009) Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling. Immunol. Cell. Biol. 87, 496-500.
164. Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., et al. (2002) Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin. Diagn. Lab. Immunol. 9, 972-982.
165. Barbeiro, D. F., Barbeiro, H. V., Zampieri, F. G., César Machado, M. C., Torggler Filho, F., et al. (2013) Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock. Microbes. Infect. 15, 342-346.
166. Carretero, M., Escamez, M. J., Garcia, M., Duarte, B., Holguin, A., et al. (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest. Dermatol. 128, 223-236.
167. Ruan, Y., Shen, T., Wang, Y., Hou, M., Li, J., et al. (2013) Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages. Int. Immunopharmacol. 15, 575-580.
168. Singh, D., Qi, R., Jordan, J. L., San Mateo, L., and Kao, C. C. (2013) The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway. J. Biol. Chem. 288, 8258-8268.
169. Schauber, J., Rieger, D., Weiler, F., Wehkamp, J., Eck, M., et al. (2006) Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 18, 615-621.
170. Morizane, S., Yamasaki, K., Muhleisen, B., Kotol, P. F., Murakami, M., et al. (2012) Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J. Invest. Dermatol. 132, 135-143.
171. Yamasaki, K., Di, N. A., Bardan, A., Murakami, M., Ohtake, T., et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13, 975-980.
172. Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., et al. (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994.
173. Putsep, K., Carlsson, G., Boman, H. G., and Andersson, M. (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149.
174. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160.
175. Realegeno, S. and Modlin, R. L. (2011) Shedding light on the vitamin D-tuberculosis-HIV connection. Proc. Natl. Acad. Sci. USA 108, 18861-18862.
176. Hoffmann, M. H., Bruns, H., Bäckdahl, L., Neregård, P., Niederreiter, B., et al. (2013) The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Ann. Rheum. Dis. 72, 1239-1248.
177. Edfeldt, K., Agerberth, B., Rottenberg, M. E., Gudmundsson, G. H., Wang, X. B., et al. (2006) Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 1551-1557.
178. Kim, H. J., Cho, D. H., Lee, K. J., Cho, C. S., Bang, S. I., et al. (2011) LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts. Exp. Dermatol. 20, 843-845.
179. Mader, J. S., Ewen, C., Hancock, R. E., and Bleackley, R. C. (2011) The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in regulatory T cells. J. Immunother. 34, 229-235.
180. Barlow, P. G., Beaumont, P. E., Cosseau, C., Mackellar, A., Wilkinson, T. S., et al. (2010) The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am. J. Respir. Cell. Mol. Biol. 43, 692-702.
181. Ciornei, C. D., Tapper, H., Bjartell, A., Sternby, N. H., and Bodelsson, M. (2006) Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc. Disord. 6, 49.
182. Zhang, Z., Cherryholmes, G., and Shively, J. E. (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J. Leukoc. Biol. 84, 780-788.
183. Jonsson, D., and Nilsson, B. O. (2012) The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J. Periodont. Res. 47, 330-335.
184. 2+-independent apoptosis. J. Innate. Immunol. 5, 290-300.
185. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) The versatility and universality of calcium signaling. Nat. Rev. Cell. Biol. 1, 11-21.
186. Orrenius, S., and Nicotera, P. (1994) The calcium ion and cell death. J. Neural. Transm. Suppl. 43, 1-11.
187. Otte, J. M., Zdebik, A. E., Brand, S., Chromik, A. M., Strauss, S., et al. (2009) Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul. Pept. 156, 104-117.
188. Zasloff, M. (2009) Antimicrobial peptides and suppression of apoptosis in human skin. J. Invest. Dermatol. 129, 824-826.
189. Nagaoka, I., Tamura, H., and Hirata, M. (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176, 3044-3052.
190. Suzuki, K., Murakami, T., Kuwahara-Arai, K., Tamura, H., Hiramatsu, K., et al. (2011) Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. Int. Immunol. 23, 185-193.
191. Hu, Z., Murakami, T., Suzuki, K., Tamura, H., Kuwahara-Arai, K., et al. (2014) Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. PLoS One 9, e85765.
192. Grönberg, A., Mahlapuu, M., Ståhle, M., Whately-Smith, C., and Rollman, O. (2014) Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial. Wound. Rep. Reg. 22, 613-621.
193. Schauber, J., Dorschner, R. A., Coda, A. B., Büchau, A. S., Liu, P. T., et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117, 803-811.
194. Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., et al. (2005) Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J. Immunol. 175, 4662-4668.
195. Chamorro, C. I., Weber, G., Grönberg, A., Pivarcsi, A., and Ståhle, M. (2009) The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J. Invest. Dermatol. 129, 937-944.
196. Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117, 91-97.
197. Bucki, R., Byfield, F. J., and Janmey, P. A. (2007) Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur. Respir. J. 29, 624-632.
198. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
199. Zhang, Z., and Shively, J. E. (2010) Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes,. PLoS One 5, e13985.
200. Coffelt, S. B., Waterman, R. S., Florez, L., Höner zu Bentrup, K., Zwezdaryk, K. J., et al. (2008) Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int. J. Cancer. 122, 1030-1039.
201. Coffelt, S. B., Tomchuck, S. L., Zwezdaryk, K. J., Danka, E. S., and Scandurro, A. B. (2009) Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol. Cancer. Res. 7, 907-915.
202. Weber, G., Chamorro, C. I., Granath, F., Liljegren, A., Zreika, S., et al. (2009) Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer. Res. 11, R6.
203. Okumura, K., Itoh, A., Isogai, E., Hirose, K., Hosokawa, Y., et al. (2004) C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett. 212, 185-194.
204. Aarbiou, J., Tjabringa, G. S., Verhoosel, R. M., Ninaber, D. K., White, S. R., et al. (2006) Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm. Res. 55, 119-127.
205. Wu, W. K., Sung, J. J., To, K. F., Yu, L., Li, H. T., et al. (2010) The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells. J. Cell. Physiol. 223, 178-186.
206. Ren, S. X., Cheng, A. S., To, K. F., Tong, J. H., Li, M. S., et al. (2012) Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. Cancer Res. 72, 6512-6523.
207. Chuang, C. M., Monie, A., Wu, A., Mao, C. P., and Hung, C. F. (2009) Treatment with LL-37 peptide enhances the antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum. Gene. Ther. 20, 303-313.